150 related articles for article (PubMed ID: 31320806)
1. Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics.
Watts ME; Wu C; Rubin LL
J Exp Neurosci; 2019; 13():1179069519862798. PubMed ID: 31320806
[TBL] [Abstract][Full Text] [Related]
2. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis.
Wu C; Watts ME; Rubin LL
Cell Rep; 2019 Jan; 26(5):1143-1156.e5. PubMed ID: 30699345
[TBL] [Abstract][Full Text] [Related]
3. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the ER stress response in ALS patient derived motor neurons identifies druggable neuroprotective targets.
Watts ME; Giadone RM; Ordureau A; Holton KM; Harper JW; Rubin LL
Front Cell Neurosci; 2023; 17():1327361. PubMed ID: 38314348
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.
Nijssen J; Comley LH; Hedlund E
Acta Neuropathol; 2017 Jun; 133(6):863-885. PubMed ID: 28409282
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.
Ranno E; D'Antoni S; Spatuzza M; Berretta A; Laureanti F; Bonaccorso CM; Pellitteri R; Longone P; Spalloni A; Iyer AM; Aronica E; Catania MV
Neurobiol Dis; 2014 May; 65():160-71. PubMed ID: 24423643
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
8. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo.
Qian K; Huang H; Peterson A; Hu B; Maragakis NJ; Ming GL; Chen H; Zhang SC
Stem Cell Reports; 2017 Apr; 8(4):843-855. PubMed ID: 28366455
[TBL] [Abstract][Full Text] [Related]
9. Sporadic amyotrophic lateral sclerosis: is SMN-Gemins protein complex of importance for the relative resistance of oculomotor nucleus motoneurons to degeneration?
Sulejczak D; Chrapusta SJ; Dziewulska D; Rafałowska J
Folia Neuropathol; 2018; 56(4):308-320. PubMed ID: 30786668
[TBL] [Abstract][Full Text] [Related]
10. The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis.
Schweingruber C; Hedlund E
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009818
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Zhang X; Li L; Chen S; Yang D; Wang Y; Zhang X; Wang Z; Le W
Autophagy; 2011 Apr; 7(4):412-25. PubMed ID: 21193837
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.
Hoye ML; Koval ED; Wegener AJ; Hyman TS; Yang C; O'Brien DR; Miller RL; Cole T; Schoch KM; Shen T; Kunikata T; Richard JP; Gutmann DH; Maragakis NJ; Kordasiewicz HB; Dougherty JD; Miller TM
J Neurosci; 2017 May; 37(22):5574-5586. PubMed ID: 28416596
[TBL] [Abstract][Full Text] [Related]
13. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model.
Wengenack TM; Holasek SS; Montano CM; Gregor D; Curran GL; Poduslo JF
Brain Res; 2004 Nov; 1027(1-2):73-86. PubMed ID: 15494159
[TBL] [Abstract][Full Text] [Related]
14. Motor Neuron Susceptibility in ALS/FTD.
Ragagnin AMG; Shadfar S; Vidal M; Jamali MS; Atkin JD
Front Neurosci; 2019; 13():532. PubMed ID: 31316328
[TBL] [Abstract][Full Text] [Related]
15. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models.
Nizzardo M; Bucchia M; Ramirez A; Trombetta E; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2016 Aug; 25(15):3152-3163. PubMed ID: 27270413
[TBL] [Abstract][Full Text] [Related]
16. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review).
Martin LJ; Price AC; Kaiser A; Shaikh AY; Liu Z
Int J Mol Med; 2000 Jan; 5(1):3-13. PubMed ID: 10601567
[TBL] [Abstract][Full Text] [Related]
18. Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Bhinge A; Namboori SC; Zhang X; VanDongen AMJ; Stanton LW
Stem Cell Reports; 2017 Apr; 8(4):856-869. PubMed ID: 28366453
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms.
Madill M; McDonagh K; Ma J; Vajda A; McLoughlin P; O'Brien T; Hardiman O; Shen S
Mol Brain; 2017 Jun; 10(1):22. PubMed ID: 28610619
[TBL] [Abstract][Full Text] [Related]
20. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
